Michael Rapp Immunome Inc. (IMNM) insider trading activity
Michael Rapp is Director of Immunome Inc.. Currently has a direct ownership of 1.07 Million shares of IMNM, which is worth approximately $15.5 Million. The most recent transaction as insider was on Oct 02, 2023, when has been sold 253,806 shares (Common Stock) at a price of $5.91 per share, resulting in proceeds of $1,499,993. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.07M
0%
3M change
31.05%
12M change
Total Value Held
$15.5 Million
MICHAEL RAPP Transaction History
MR
Michael Rapp
Director
Exton, PA